These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 20100686)
1. Evolution of capecitabine dosing in colorectal cancer. Sun W Clin Colorectal Cancer; 2010 Jan; 9(1):31-9. PubMed ID: 20100686 [TBL] [Abstract][Full Text] [Related]
2. Capecitabine plus oxaliplatin for the treatment of colorectal cancer. Carrato A; Gallego-Plazas J; Guillén-Ponce C Expert Rev Anticancer Ther; 2008 Feb; 8(2):161-74. PubMed ID: 18279056 [TBL] [Abstract][Full Text] [Related]
3. Dosing considerations for capecitabine-irinotecan regimens in the treatment of metastatic and/or locally advanced colorectal cancer. Cartwright T; McCollum D; Boehm KA Am J Clin Oncol; 2010 Jun; 33(3):307-13. PubMed ID: 20375835 [TBL] [Abstract][Full Text] [Related]
4. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer. Iqbal S; Lenz HJ Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325 [TBL] [Abstract][Full Text] [Related]
5. Capecitabine: a review. Walko CM; Lindley C Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604 [TBL] [Abstract][Full Text] [Related]
6. Capecitabine: an overview of the side effects and their management. Saif MW; Katirtzoglou NA; Syrigos KN Anticancer Drugs; 2008 Jun; 19(5):447-64. PubMed ID: 18418212 [TBL] [Abstract][Full Text] [Related]
7. [Capecitabine]. Yamaguchi K; Shimamura T; Tada M Gan To Kagaku Ryoho; 2006 Jul; 33(7):891-5. PubMed ID: 16835474 [TBL] [Abstract][Full Text] [Related]
8. Update on capecitabine alone and in combination regimens in colorectal cancer patients. Silvestris N; Maiello E; De Vita F; Cinieri S; Santini D; Russo A; Tommasi S; Azzariti A; Numico G; Pisconti S; Petriella D; Lorusso V; Millaku A; Colucci G Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S46-55. PubMed ID: 21129610 [TBL] [Abstract][Full Text] [Related]
9. New options for outpatient chemotherapy--the role of oral fluoropyrimidines. Cunningham D; Coleman R Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. Hochster HS; Hart LL; Ramanathan RK; Childs BH; Hainsworth JD; Cohn AL; Wong L; Fehrenbacher L; Abubakr Y; Saif MW; Schwartzberg L; Hedrick E J Clin Oncol; 2008 Jul; 26(21):3523-9. PubMed ID: 18640933 [TBL] [Abstract][Full Text] [Related]
11. MTHFR polymorphisms and capecitabine-induced toxicity in patients with metastatic colorectal cancer. van Huis-Tanja LH; Gelderblom H; Punt CJ; Guchelaar HJ Pharmacogenet Genomics; 2013 Apr; 23(4):208-18. PubMed ID: 23407049 [TBL] [Abstract][Full Text] [Related]
12. Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparison. Chu E; Schulman KL; McKenna EF; Cartwright T Clin Colorectal Cancer; 2010 Oct; 9(4):229-37. PubMed ID: 20920995 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials. Arkenau HT; Arnold D; Cassidy J; Diaz-Rubio E; Douillard JY; Hochster H; Martoni A; Grothey A; Hinke A; Schmiegel W; Schmoll HJ; Porschen R J Clin Oncol; 2008 Dec; 26(36):5910-7. PubMed ID: 19018087 [TBL] [Abstract][Full Text] [Related]
14. A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors. Dennie TW; Fleming RA; Bowen CJ; Dar MM; Alberti D; Oliver K; Loconte N; Mulkerin D; Holen KD Clin Colorectal Cancer; 2011 Mar; 10(1):57-62. PubMed ID: 21609937 [TBL] [Abstract][Full Text] [Related]
15. Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy. Koukourakis G; Kouloulias V; Zacharias G; Koukourakis M J BUON; 2010; 15(4):652-9. PubMed ID: 21229625 [TBL] [Abstract][Full Text] [Related]
16. Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108. Comella P; Natale D; Farris A; Gambardella A; Maiorino L; Massidda B; Casaretti R; Tafuto S; Lorusso V; Leo S; Cannone M Cancer; 2005 Jul; 104(2):282-9. PubMed ID: 15948167 [TBL] [Abstract][Full Text] [Related]
17. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin. Hennig IM; Naik JD; Brown S; Szubert A; Anthoney DA; Jackson DP; Melcher AM; Crawford SM; Bradley C; Brown JM; Seymour MT J Clin Oncol; 2008 Jul; 26(20):3411-7. PubMed ID: 18612156 [TBL] [Abstract][Full Text] [Related]
18. Capecitabine (Xeloda): from the laboratory to the patient's home. Pentheroudakis G; Twelves C Clin Colorectal Cancer; 2002 May; 2(1):16-23. PubMed ID: 12453332 [TBL] [Abstract][Full Text] [Related]